179
Views
21
CrossRef citations to date
0
Altmetric
Articles

Fabrication and Biocompatibility of an Antimicrobial Composite Membrane with an Asymmetric Porous Structure

, , , , , , & show all
Pages 81-96 | Published online: 13 Apr 2012
 

Abstract

A composite slurry from silver ion-substituted nano-hydroxyapatite, titania nano-particles and polyamide 66 (Ag-nHA/TiO2/PA66) was prepared and used to fabricate a novel antimicrobial membrane with a gradient porous structure for guided bone regeneration (GBR). Subsequently, assays were performed to determine the cytocompatibility, as well as the bone biocompatibility of the prepared membranes. To investigate the cytocompatibility of the Ag-nHA/TiO2/PA66 membrane, in vitro studies were done with osteoblast-like cells (MG63) and the viability, alkaline phosphatase activity (ALP) and morphology of cells cultured on the membrane were determined. The bone biocompatibility of the membranes was finally assessed in animal experiments, in which nano-hydroxyapatite/polyamide 66 (nHA/PA66) and pure polyamide 66 (PA66) membranes were compared. The in vitro cell-culture experiments showed that Ag-nHA/TiO2/PA66 antimicrobial membrane evoked good cell affinity and cytocompatibility. The in vivo study showed that Ag-nHA/TiO2/PA66 asymmetric porous barrier membrane resulted in complete closure of 5-mm bone defects as created in the skull of rats after 8 weeks of implantation. In conclusion, the Ag-nHA/TiO2/PA66 membrane has the potential to be applied in GBR, especially in infected tissue or areas with high bacteria concentration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.